Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Routine hepatitis A childhood vaccination highly effective preventative measure

A project that offered free hepatitis A vaccination to children was highly effective in preventing the disease among recipients, according to an article in the latest issue of the Journal of the American Medical Association.

News image

fiogf49gjkf04

The project also appears to have decreased the incidence of hepatitis A among both children and adults and controlled the disease in a community with recurrent epidemics.

Francisco Averhoff, of the Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues conducted a community-based demonstration project from 12 January 1995 through 31 December 2000, in Butte County, California.

Butte County had recurrent outbreaks of hepatitis A between 1985 and 1994.

The 1994 rate was highest among children younger than the age of 15 (193.0 per 100,000 population).

For the Butte County project, vaccination was offered to children aged 2 to 12, during vaccination clinics conducted at most schools in the county in 1995. This was done on two occasions, 6 to 12 months apart.

Between 1996 and 2000, vaccine was distributed to community health care clinicians who vaccinated eligible children without charge.

Vaccine was also available at health department clinics, selected childcare centers, and other sites.

During the study period, 29,789 (66.2%) of an estimated 44,982 eligible children received at least one vaccine dose; 17,681 (39.3%) received a second dose.

"The number of hepatitis A cases among the entire county population declined 93.5% during the study period, from 57 cases in 1995 to 4 in 2000.

"This is the lowest number of cases reported in the county since hepatitis A surveillance began in 1966," the authors report.

"The 2000 incidence rate of 1.9 per 100,000 population was the lowest of any county in the state.

Number of hepatitis A cases declined 94% between 1995 and 2000.
Journal of the American Medical Association

"Of the 245 cases reported during the 6-year period, 40 (16.3%) occurred among children 17 years of age or younger, of which 16 (40%) occurred in 1995 and only 1 in 2000," they write.

"One of the 27 case patients eligible for vaccination had been vaccinated, having received the first dose 3 days before symptom onset."

"The estimated protective vaccine efficacy was 98%," the authors report.

No serious adverse events were reported among the vaccine recipients, supporting the safety of hepatitis A vaccination.

"This 6-year project demonstrated the feasibility and effectiveness of routine childhood hepatitis A vaccination and its impact on community-wide rates of disease," the authors assert.

"The decline appears to be sustained; only 2 cases were reported to the CDC during the first half of 2001," they report, citing unpublished CDC data.

"The Butte County experience suggests that, over time, routine vaccination of children can reduce overall disease rates in the community.

"This previews the potential impact of routine childhood hepatitis A vaccination, as recently recommended by the Advisory Committee on Immunization Practices for areas of the United States with consistently high hepatitis A infection rates," the authors conclude.

JAMA 2001; 286: 2968-73
19 December 2001

Go to top of page Email this page Email this page to a colleague

 24 May 2018 
Precision medicine for tumors
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us